B. Riley Securities Reiterates Buy on CytoSorbents, Maintains $3 Price Target
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities has reiterated its Buy rating on CytoSorbents (NASDAQ:CTSO) and maintained a price target of $3.
May 15, 2024 | 2:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B. Riley Securities has reiterated its Buy rating on CytoSorbents and maintained a price target of $3.
The reiteration of a Buy rating and the maintenance of a $3 price target by B. Riley Securities is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100